US Stock MarketDetailed Quotes

ADMA ADMA Biologics

Watchlist
  • 17.010
  • +1.180+7.45%
Close Mar 4 16:00 ET
4.02BMarket Cap21.00P/E (TTM)

ADMA Biologics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
65.15%426.45M
59.06%117.55M
78.13%119.84M
78.29%107.19M
43.86%81.88M
67.59%258.22M
47.86%73.9M
63.73%67.28M
77.33%60.12M
95.56%56.91M
Operating revenue
65.15%426.45M
59.06%117.55M
78.13%119.84M
78.29%107.19M
43.86%81.88M
67.59%258.22M
47.86%73.9M
63.73%67.28M
77.33%60.12M
95.56%56.91M
Cost of revenue
22.23%206.9M
26.62%54.22M
41.19%60.18M
14.52%49.74M
5.86%42.77M
42.47%169.27M
19.59%42.82M
35.59%42.62M
66.18%43.43M
58.80%40.4M
Gross profit
146.85%219.55M
103.73%63.33M
141.99%59.66M
244.24%57.45M
136.83%39.11M
152.21%88.94M
119.27%31.09M
155.30%24.65M
114.82%16.69M
350.92%16.51M
Operating expense
19.70%80.57M
48.40%25.01M
25.38%20.02M
6.35%18.25M
-0.23%17.29M
-9.81%67.31M
-16.72%16.85M
-15.84%15.97M
1.29%17.16M
-6.23%17.33M
Selling and administrative expenses
25.59%74.12M
50.09%23.32M
26.04%18.56M
16.56%16.61M
7.77%15.64M
12.51%59.02M
11.80%15.54M
14.22%14.73M
19.03%14.25M
5.93%14.51M
Research and development costs
-45.06%1.81M
-12.33%391K
-30.87%412K
-60.09%560K
-47.37%450K
-8.69%3.3M
-58.49%446K
-42.80%596K
60.64%1.4M
36.99%855K
Depreciation amortization depletion
-46.41%388K
-86.63%25K
-84.36%28K
-20.67%142K
7.82%193K
1.26%724K
4.77%187K
0.09%179K
0.09%179K
0.09%179K
-Depreciation and amortization
-46.41%388K
-86.63%25K
-84.36%28K
-20.67%142K
7.82%193K
1.26%724K
4.77%187K
0.09%179K
0.09%179K
0.09%179K
Other operating expenses
-0.49%4.25M
86.42%1.28M
118.63%1.02M
-29.33%942K
-43.54%1.01M
-76.09%4.27M
-86.54%685K
-90.39%467K
-66.01%1.33M
-55.22%1.78M
Operating profit
542.49%138.98M
169.25%38.32M
356.40%39.64M
8,387.74%39.2M
2,784.01%21.82M
154.95%21.63M
334.93%14.23M
193.22%8.69M
94.84%-473K
94.51%-813K
Net non-operating interest income expense
49.45%-11.83M
59.29%-2.28M
52.59%-2.83M
43.35%-3.33M
43.10%-3.39M
-21.71%-23.41M
2.29%-5.6M
-7.21%-5.98M
-28.75%-5.89M
-77.27%-5.95M
Non-operating interest income
29.68%2.1M
-2.29%598K
57.45%666K
8.45%449K
131.33%384K
3,493.33%1.62M
25,116.32%612K
5,745.77%423K
18,145.92%414K
402.00%166K
Non-operating interest expense
-44.34%13.93M
-53.68%2.88M
-45.31%3.5M
-39.94%3.78M
-38.36%3.77M
29.81%25.03M
8.34%6.22M
14.65%6.4M
37.74%6.3M
80.43%6.12M
Other net income (expense)
94.57%-1.44M
94.94%-1.33M
61.38%-56K
-23.08%-16K
-29.63%-35K
-262.23%-26.46M
-5,883.60%-26.28M
-1,403.99%-145K
33.06%-13K
99.61%-27K
Special income (charges)
95.25%-1.24M
---1.24M
----
----
----
-292.41%-26.17M
----
----
----
----
-Less:Other special charges
-95.25%1.24M
--1.24M
----
----
----
292.41%26.17M
----
----
----
----
Other non- operating income (expenses)
32.75%-193K
14.85%-86K
61.38%-56K
-23.08%-16K
-29.63%-35K
54.80%-287K
77.00%-101K
-1,403.99%-145K
33.06%-13K
83.82%-27K
Income before tax
545.18%125.71M
296.73%34.71M
1,332.71%36.75M
662.72%35.85M
371.04%18.4M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
Income tax
-71.96M
-77.18M
840K
3.79M
595K
0
0
0
Net income
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
Net income continuous Operations
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
Minority interest income
Net income attributable to the parent company
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
800.00%197.67M
734.15%111.9M
1,299.96%35.91M
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.26%-17.65M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
Basic earnings per share
753.85%0.85
687.50%0.47
1,400.00%0.15
566.67%0.14
366.67%0.08
60.61%-0.13
-33.33%-0.08
112.50%0.01
57.14%-0.03
76.92%-0.03
Diluted earnings per share
723.08%0.81
675.00%0.46
1,400.00%0.15
533.33%0.13
366.67%0.08
60.61%-0.13
-33.33%-0.08
112.50%0.01
57.14%-0.03
76.92%-0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 65.15%426.45M59.06%117.55M78.13%119.84M78.29%107.19M43.86%81.88M67.59%258.22M47.86%73.9M63.73%67.28M77.33%60.12M95.56%56.91M
Operating revenue 65.15%426.45M59.06%117.55M78.13%119.84M78.29%107.19M43.86%81.88M67.59%258.22M47.86%73.9M63.73%67.28M77.33%60.12M95.56%56.91M
Cost of revenue 22.23%206.9M26.62%54.22M41.19%60.18M14.52%49.74M5.86%42.77M42.47%169.27M19.59%42.82M35.59%42.62M66.18%43.43M58.80%40.4M
Gross profit 146.85%219.55M103.73%63.33M141.99%59.66M244.24%57.45M136.83%39.11M152.21%88.94M119.27%31.09M155.30%24.65M114.82%16.69M350.92%16.51M
Operating expense 19.70%80.57M48.40%25.01M25.38%20.02M6.35%18.25M-0.23%17.29M-9.81%67.31M-16.72%16.85M-15.84%15.97M1.29%17.16M-6.23%17.33M
Selling and administrative expenses 25.59%74.12M50.09%23.32M26.04%18.56M16.56%16.61M7.77%15.64M12.51%59.02M11.80%15.54M14.22%14.73M19.03%14.25M5.93%14.51M
Research and development costs -45.06%1.81M-12.33%391K-30.87%412K-60.09%560K-47.37%450K-8.69%3.3M-58.49%446K-42.80%596K60.64%1.4M36.99%855K
Depreciation amortization depletion -46.41%388K-86.63%25K-84.36%28K-20.67%142K7.82%193K1.26%724K4.77%187K0.09%179K0.09%179K0.09%179K
-Depreciation and amortization -46.41%388K-86.63%25K-84.36%28K-20.67%142K7.82%193K1.26%724K4.77%187K0.09%179K0.09%179K0.09%179K
Other operating expenses -0.49%4.25M86.42%1.28M118.63%1.02M-29.33%942K-43.54%1.01M-76.09%4.27M-86.54%685K-90.39%467K-66.01%1.33M-55.22%1.78M
Operating profit 542.49%138.98M169.25%38.32M356.40%39.64M8,387.74%39.2M2,784.01%21.82M154.95%21.63M334.93%14.23M193.22%8.69M94.84%-473K94.51%-813K
Net non-operating interest income expense 49.45%-11.83M59.29%-2.28M52.59%-2.83M43.35%-3.33M43.10%-3.39M-21.71%-23.41M2.29%-5.6M-7.21%-5.98M-28.75%-5.89M-77.27%-5.95M
Non-operating interest income 29.68%2.1M-2.29%598K57.45%666K8.45%449K131.33%384K3,493.33%1.62M25,116.32%612K5,745.77%423K18,145.92%414K402.00%166K
Non-operating interest expense -44.34%13.93M-53.68%2.88M-45.31%3.5M-39.94%3.78M-38.36%3.77M29.81%25.03M8.34%6.22M14.65%6.4M37.74%6.3M80.43%6.12M
Other net income (expense) 94.57%-1.44M94.94%-1.33M61.38%-56K-23.08%-16K-29.63%-35K-262.23%-26.46M-5,883.60%-26.28M-1,403.99%-145K33.06%-13K99.61%-27K
Special income (charges) 95.25%-1.24M---1.24M-------------292.41%-26.17M----------------
-Less:Other special charges -95.25%1.24M--1.24M------------292.41%26.17M----------------
Other non- operating income (expenses) 32.75%-193K14.85%-86K61.38%-56K-23.08%-16K-29.63%-35K54.80%-287K77.00%-101K-1,403.99%-145K33.06%-13K83.82%-27K
Income before tax 545.18%125.71M296.73%34.71M1,332.71%36.75M662.72%35.85M371.04%18.4M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M
Income tax -71.96M-77.18M840K3.79M595K000
Net income 800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M
Net income continuous Operations 800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M
Minority interest income
Net income attributable to the parent company 800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 800.00%197.67M734.15%111.9M1,299.96%35.91M603.25%32.06M362.28%17.81M57.15%-28.24M-44.26%-17.65M117.22%2.57M53.72%-6.37M72.85%-6.79M
Basic earnings per share 753.85%0.85687.50%0.471,400.00%0.15566.67%0.14366.67%0.0860.61%-0.13-33.33%-0.08112.50%0.0157.14%-0.0376.92%-0.03
Diluted earnings per share 723.08%0.81675.00%0.461,400.00%0.15533.33%0.13366.67%0.0860.61%-0.13-33.33%-0.08112.50%0.0157.14%-0.0376.92%-0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.